Literature DB >> 3297323

A monoclonal antibody (Po66) directed against human lung squamous cell carcinoma immunolocalization of tumour xenografts in nude mice.

L Dazord, D Bourel, A Martin, R Lecorre, P Bourguet, J Bohy, J C Saccavini, P Delaval, M Louvet, L Toujas.   

Abstract

Po66, a mouse IgG1 monoclonal antibody, was produced by immunization against a patient lung squamous cell carcinoma. The tissue reactivity of the antibody was measured by a radioimmunological assay with enzymatically dissociated cells, by an immunofluorescence test on frozen tissue sections and by peroxidase-staining of paraffin sections. The antibody bound to lung squamous cell carcinoma, oesophagus carcinoma and, inconsistently to lung adenocarcinoma but not to the other tumours tested. Some normal tissues also reacted positively, in particular bronchial serous glands, oesophagus epithelium and renal distal and collecting tubules. In normal and malignant tissues showing epithelioid differentiation, Po66 bound to the intermediate maturation area. The antigen immunoprecipitated by Po66 from lung squamous cell carcinoma appeared as a single band with a molecular weight 47,000 to 50,000 daltons. Purified monoclonal antibody Po66 and an unrelated IgG1 immunoglobulin were labelled with radioactive iodine and injected i.v. into nude mice bearing subcutaneous xenografts of human lung squamous cell carcinoma. The localization index in the tumour was 3.3. Antibody labelled with 131I allowed gamma-scintigraphic imaging of the xenografts which were clearly outlined by days 9 to 11.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297323     DOI: 10.1007/BF00205641

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  20 in total

1.  Monoclonal antibodies and human tumours: pathological and clinical aspects.

Authors:  A M Neville; B A Gusterson
Journal:  Eur J Cancer Clin Oncol       Date:  1985-03

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  The mouse Lyt-2/3 antigen complex--I. Mode of association of the subunits with the membrane.

Authors:  B Luescher; H Y Naim; H R MacDonald; C Bron
Journal:  Mol Immunol       Date:  1984-04       Impact factor: 4.407

5.  Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.

Authors:  B G Brenner; S Jothy; J Shuster; A Fuks
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

6.  Limiting factors in the localization of tumours with radiolabelled antibodies.

Authors:  A R Bradwell; D S Fairweather; P W Dykes; A Keeling; A Vaughan; J Taylor
Journal:  Immunol Today       Date:  1985-05

7.  Monoclonal antibodies that distinguish non-small cell from small cell lung cancer.

Authors:  J L Mulshine; F Cuttitta; M Bibro; J Fedorko; S Fargion; C Little; D N Carney; A F Gazdar; J D Minna
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

8.  Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.

Authors:  P J Harwood; R B Pedley; J Boden; G Rawlins; C R Pentycross; G T Rogers; K D Bagshawe
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

Review 9.  Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.

Authors:  P A Edwards
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

10.  Antibodies from EB-virus-transformed lymphocytes of lymph nodes adjoining lung cancer.

Authors:  S Hirohashi; Y Shimosato; Y Ino
Journal:  Br J Cancer       Date:  1982-11       Impact factor: 7.640

View more
  7 in total

1.  Characterization of the antigen identified by Po66. A monoclonal antibody raised against a lung squamous cell carcinoma.

Authors:  A Martin; P Pellen; C Guitton; P Youinou; B Collet; B Desrues; D Bourel; L Dazord; L Toujas
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 2.  Tumor galectinology: insights into the complex network of a family of endogenous lectins.

Authors:  Harald Lahm; Sabine André; Andreas Hoeflich; Herbert Kaltner; Hans-Christian Siebert; Bernard Sordat; Claus-Wilhelm von der Lieth; Eckhard Wolf; Hans-Joachim Gabius
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

3.  Scintigraphic detection in mice of inflammatory lesions and tumours by an indium-labelled monoclonal antibody directed against Mac-1 antigen.

Authors:  B Collet; P Pellen; A Martin; A Moisan; D Bourel; L Toujas
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 4.  Human galectin-8 isoforms and cancer.

Authors:  Nathalie Bidon-Wagner; Jean-Paul Le Pennec
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

5.  Immunoscintigraphy of human lung squamous cell carcinoma using an iodine-131 labelled monoclonal antibody (Po66).

Authors:  P Bourguet; L Dazord; B Desrues; B Collet; M P Ramee; P Delaval; A Martin; Y Logeais; A Pelletier; L Toujas
Journal:  Br J Cancer       Date:  1990-02       Impact factor: 7.640

6.  Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.

Authors:  B Desrues; H Léna; F Brichory; M P Ramée; L Toujas; P Delaval; L Dazord
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

7.  Role of galectins in lung cancer.

Authors:  Wei-An Chang; Ming-Ju Tsai; Po-Lin Kuo; Jen-Yu Hung
Journal:  Oncol Lett       Date:  2017-09-04       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.